Modalis Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	May '25 May 29, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	5,696	7,079	3,916	9,769	17,753	63,031	Upgrade
Market Cap Growth	94.86%	80.79%	-59.92%	-44.97%	-71.84%	-	Upgrade
Enterprise Value	2,136	4,592	2,019	6,088	12,290	57,413	Upgrade
Last Close Price	76.00	102.00	124.00	335.00	613.00	2212.00	Upgrade
Forward PE	-	-	-	43.68	17.75	113.00	Upgrade
PS Ratio	-	-	-	244.24	17752.87	184.30	Upgrade
PB Ratio	1.72	2.00	2.84	3.32	3.20	10.15	Upgrade
P/TBV Ratio	1.72	2.00	2.84	3.32	3.67	11.59	Upgrade
EV/Sales Ratio	-	-	-	152.21	12289.87	167.87	Upgrade
Debt / Equity Ratio	-	-	0.30	-	-	-	Upgrade
Asset Turnover	-	-	-	0.01	0	0.07	Upgrade
Quick Ratio	10.39	30.56	9.51	20.80	27.42	93.47	Upgrade
Current Ratio	10.52	30.92	9.88	21.71	28.15	93.93	Upgrade
Return on Equity (ROE)	-69.94%	-53.48%	-110.75%	-63.67%	-12.55%	-8.92%	Upgrade
Return on Assets (ROA)	-54.68%	-29.24%	-57.48%	-28.04%	-12.54%	-4.87%	Upgrade
Return on Capital (ROIC)	-61.09%	-31.31%	-62.63%	-30.38%	-13.17%	-4.95%	Upgrade
Earnings Yield	-26.55%	-18.60%	-61.06%	-27.66%	-4.16%	-0.71%	Upgrade
FCF Yield	-	-20.23%	-58.56%	-21.41%	-4.81%	-0.62%	Upgrade
Buyback Yield / Dilution	-74.57%	-48.96%	-6.39%	-1.23%	-9.12%	-11.78%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.